2018
DOI: 10.1016/j.cell.2018.06.031
|View full text |Cite
|
Sign up to set email alerts
|

Diet-Induced Circadian Enhancer Remodeling Synchronizes Opposing Hepatic Lipid Metabolic Processes

Abstract: Overnutrition disrupts circadian metabolic rhythms by mechanisms that are not well understood. Here, we show that diet-induced obesity (DIO) causes massive remodeling of circadian enhancer activity in mouse liver, triggering synchronous high-amplitude circadian rhythms of both fatty acid (FA) synthesis and oxidation. SREBP expression was rhythmically induced by DIO, leading to circadian FA synthesis and, surprisingly, FA oxidation (FAO). DIO similarly caused a high-amplitude circadian rhythm of PPARα, which wa… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

8
156
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 153 publications
(165 citation statements)
references
References 78 publications
8
156
0
Order By: Relevance
“…Following lentiviral transduction, cells are synchronized in vitro by various stimuli and subjected to circadian bioluminescence recording during several days. [39][40][41][42]187,190 Photomultiplier tube-based measurements are sued to conduct population analysis of cellular rhythms (upper schema), 210 taken into account when administrating metformin, 206 lipid lowering drugs, 127 inflammatory drugs targeting the glucocorticoid receptor 122,207 and many other therapeutic agents.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Following lentiviral transduction, cells are synchronized in vitro by various stimuli and subjected to circadian bioluminescence recording during several days. [39][40][41][42]187,190 Photomultiplier tube-based measurements are sued to conduct population analysis of cellular rhythms (upper schema), 210 taken into account when administrating metformin, 206 lipid lowering drugs, 127 inflammatory drugs targeting the glucocorticoid receptor 122,207 and many other therapeutic agents.…”
Section: Discussionmentioning
confidence: 99%
“…30,109,[112][113][114][115][116][117][118][119][120] In skeletal muscle, REV-ERBα directly represses enzymes essential for lipid and protein metabolism, along with BMAL1, which activates key regulators of lipid metabolism. 127 Additionally, the RNA-binding protein NONO situated in liver cell nuclei couples the rhythmic expression of metabolic genes with nutrient levels, with NONO-deficient mice exhibiting impaired glucose tolerance as well as lower hepatic glycogen and lipid content. 121 In the liver, REV-ERBα couples glucocorticoid signalling to energy metabolism via binding of the hepatocyte nuclear transcription factors HNF4A/HNF6.…”
Section: Of Mammalian Physiology and Metabolismmentioning
confidence: 99%
See 1 more Smart Citation
“…In the liver, it leads to activation of lipid-related transcription factors at a specific circadian time, promoting oscillation of transcriptional pathways involved in fatty acid synthesis, fatty acid oxidation, and glycerophospholipid metabolism. Paralleling gene transcription, a number of lipid metabolites also follow a similar pattern of gain of oscillation (Eckel-Mahan et al, 2013;Guan et al, 2018). A mouse study indicated that targeting PPAR-α-a major regulator of lipid metabolism-at its peak expression with an agonist used in the clinic for hyperlipidemia resulted in greater efficacy at lowering hepatic lipid accumulation when delivered (Guan et al, 2018).…”
Section: Environment Mattersmentioning
confidence: 99%
“…When comparing young versus old mice, Sato et al () observed age induced reprogramming of the circadian hepatic transcript and chromatin landscapes. However, caloric restriction, which has been associated with clock re‐setting (Guan et al, ), counteracted age‐dependent changes (S. Sato et al, ). Earlier work has also established the role of body temperature as a universal cue in mammalian circadian transcriptional regulation (Buhr, Yoo, & Takahashi, ).…”
Section: Liver Enhancer Dynamicsmentioning
confidence: 99%